(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network!. Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Market Surge: Nuburu's NASA Contract, Novavax's Surprise Profit

August 08th, 2023

Shares of Nuburu, Inc. (NYSE American: BURU) surged over 150% in pre-market trading as the company unveiled a groundbreaking contract with NASA. The contract is set to demonstrate the feasibility of NUBURU's innovative Blue Laser technology for po. Read more

Biophytis Gains Momentum; bluebird bio Posts Mixed Results

August 08th, 2023

Shares of Biophytis S.A. (Nasdaq: BPTS) surged over 10% in pre-market trading as the company secured a favorable opinion from Belgian authorities for its groundbreaking SARA-31 program.  This initiative marks the first-ever phase 3 study targ. Read more

Q2 Earnings: AMC Entertainment and RadNet Beat Expectations

August 08th, 2023

AMC Entertainment Holdings, Inc. (NYSE: AMC) has released its second-quarter 2023 financial report, surprising analysts with earnings per share (EPS) of $0.00 and revenues amounting to $1.35 billion. This outperformed the consensus forecast of a loss. Read more

Beyond Meat Posts Mixed Results; CRISPR Therapeutics Tops Estimates

August 08th, 2023

Beyond Meat, Inc. (Nasdaq: BYND) has reported a second-quarter 2023 loss of $0.83 per share, slightly better than the consensus estimated loss of $0.86 per share. However, quarterly revenues of $102.10 million fell short of the analysts' projected $1. Read more

Earnings Reaction Rollercoaster: Chegg Rises, Alteryx Dips

August 07th, 2023

Chegg, Inc. (NYSE: CHGG) announced second-quarter 2023 earnings per share (EPS) of $0.28 and revenues amounting to $182.85 million, surpassing the consensus EPS estimate of $0.29 on revenues of $176.51 million. $CHGG was trading at $12.45 in after. Read more

Breaking: Tyson Foods Q3 Misses Mark; Ginkgo Bioworks' Merck Deal Shakes Up

August 07th, 2023

Tyson Foods, Inc. (NYSE: TSN) has released its third-quarter fiscal 2023 financial results, reporting adjusted earnings per share (EPS) of $0.15 and revenues totaling $13.14 billion. These figures fell short of market consensus estimates of $0.26 EPS. Read more

Sohu.com's Q2 Revenue Dips; Henry Schein Posts Mixed Results

August 07th, 2023

Sohu.com Limited (Nasdaq: SOHU) revealed its unaudited second quarter 2023 financial results, reporting a total revenue of $152 million, down 22% year-over-year and 6% sequentially.  The company reported a Non-GAAP net loss of $18 million, tr. Read more

Kosmos Energy Falls Short in Q2; Bullish View On Cigna and EchoStar

August 07th, 2023

Energy exploration and production company Kosmos Energy Ltd. (NYSE: KOS) announced its second-quarter 2023 financial results, reporting an earnings per share (EPS) of $0.05 and total revenues of $273.32 million. These figures fell short of the market. Read more

Earnings Preview: CyberArk, Veru, Affimed, and Credicorp in the Spotlight

August 06th, 2023

On Thursday, August 10, a lineup of companies is slated to present their financial performance, unveiling valuable insights into their recent activities and market dynamics. These companies include: CyberArk Software Ltd. (Nasdaq: CYBR), a leader . Read more

Key Metrics: Illumina, CleanSpark, MaxCyte, and Proterra's Earnings Preview

August 06th, 2023

A lineup of companies is poised to reveal their financial insights on Wednesday, August 9, shedding light on their recent performances and market trends. These companies include: Illumina, Inc. (Nasdaq: ILMN), a leader in genetic sequencing and an. Read more